An active metabolite of eicosapentaenoic acid and an S1P1 agonist
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

(±)17(18)-EpETE

Item No. 50861

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
rel-(17S,18R)-epoxy-5Z,8Z,11Z,14Z-eicosatetraenoic acid
Synonyms
  • (±)17(18)-EEQ
  • (±)17(18)-epoxy-5(Z),8(Z)
  • (±)17(18)-epoxy-all-cis-5,8,11,14-Eicosatetraenoic Acid
  • (±)17(18)-Epoxyeicosatetraenoic Acid
  • 11(Z),14(Z)-ETE
  • FA 20:5;O
Molecular Formula
C20H30O3
Formula Weight
318.5
Purity
≥90%
Formulation (Request formulation change)
A 100 µg/ml solution in ethanol
Solubility(Learn about Variance in Solubility)
DMF: 50 mg/mlDMSO: 50 mg/mlEthanol: 50 mg/mlPBS (pH 7.2): 1 mg/ml
SMILES
CC[C@@H]1[C@@H](O1)C/C=C\C/C=C\C/C=C\C/C=C\CCCC(O)=O.CC[C@H]2[C@H](O2)C/C=C\C/C=C\C/C=C\C/C=C\CCCC(O)=O
InChi Code
InChI=1S/2C20H30O3/c2*1-2-18-19(23-18)16-14-12-10-8-6-4-3-5-7-9-11-13-15-17-20(21)22/h2*3,5-6,8-9,11-12,14,18-19H,2,4,7,10,13,15-17H2,1H3,(H,21,22)/b2*5-3-,8-6-,11-9-,14-12-/t18-,19+;18-,19-/m01/s1
InChi Key
KWSANWNLWZVOSU-LGROVTKTSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    25 µg

    $75

    Add

    50 µg

    $143

    Add

    100 µg

    $270

    Add

    500 µg

    $975

    Add
    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    (±)17(18)-EpETE is an active metabolite of the ω-3 fatty acid eicosapentaenoic acid (EPA; Item Nos. 90110 | 90110.1 | 21908) formed via epoxidation of the 17,18 double bond by the cytochrome P450 (CYP) isoform CYP1A2 and an agonist of sphingosine-1-phosphate receptor 1 (S1P1).1,2 It binds to S1P1 (Ki = 0.57 nM) and activates S1P1 in a bioluminescence resonance energy transfer (BRET) assay using HEK293T cells expressing human S1P1 (EC50 = 8.93).1 (±)17(18)-EpETE (100 nM) also increases outward potassium efflux in rat vascular smooth muscle cells expressing large-conductance calcium-activated potassium channels (KCa1.1/BK).3 It inhibits oscillatory shear stress- or TNF-α-induced increases in vascular cell adhesion molecule-1 (VCAM1) levels in human umbilical vein endothelial cells (HUVECs) in a concentration-dependent manner.1 (±)17(18)-EpETE (1 µM) increases levels of phosphorylated endothelial nitric oxide synthase (eNOS), as well as prevents TNF-α-induced increases in levels of IκBα and phosphorylated levels of IKKα and p65 in HUVECs. In vivo, (±)17(18)-EpETE decreases tissue levels of VCAM1 and intracellular adhesion molecule-1 (ICAM1) and reduces the number of atherosclerotic lesions in the carotid arteries of wild-type but not S1pr1-/- mice in a model of atherosclerosis induced by arterial ligation and the Pcsk9 mutant Pcsk9N377Y.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Zhou, T., Cheng, J., He, S., et al. The sphingosine-1-phosphate receptor 1 mediates the atheroprotective effect of eicosapentaenoic acid. Nat. Metab. 6(8), 1566-1583 (2024).

    2. Isobe, Y., Itagaki, M., ito, Y., et al. Comprehensive analysis of the mouse cytochrome P450 family responsible for omega-3 epoxidation of eicosapentaenoic acid. Sci. Rep. 8(1), 7954 (2018).

    3. Lauterbach, B., Barbosa-Sicard, E., Wang, M.H., et al. Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators. Hypertension 39(2 Pt. 2), 609-613 (2002).

    Product Citations

    Walker, R.E., Savinova, O.V., Pedersen, T.L., et al. Effects of inflammation and soluble epoxide hydrolase inhibition on oxylipin composition of very low-density lipoproteins in isolated perfused rat livers. Physiol. Rep. 9(4), e14480 (2021).

    Caires, R., Sierra-Valdez, F.J., Millet, J.R.M., et al. Omega-3 fatty acids modulate TRPV4 function through plasma membrane remodeling. Cell Reports 21, 245-258 (2017).

    McDougle, D.R., Watson, J.E., Abdeen, A.A., et al. Anti-inflammatory ω-3 endocannabinoid epoxides. Proc. Natl. Acad. Sci. USA 114(30), E6034-E6043 (2017).

    Aoyagi, R., Ikeda, K., Isobe, Y., et al. Comprehensive analyses of oxidized phospholipids using a measured MS/MS spectra library. J. Lipid. Res. 58(11), 2229-2237 (2017).